DRESS syndrome diagnostic criteria: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 11: Line 11:
{| class="wikitable"
{| class="wikitable"
|-
|-
! RegiSCAR inclusion criteria for DRESS syndrome. At least three of the four starred criteria are required for diagnosis !! Japanese consensus group diagnostic criteria for DIHS. Seven criteria needed for the diagnosis of DRESS syndrome or the first five criteria required for diagnosis of atypical DIHS
! RegiSCAR inclusion criteria for DRESS syndrome.<br>''At least three of the four starred criteria are required for diagnosis'' !! Japanese consensus group diagnostic criteria for DIHS.<br>''Seven criteria needed for the diagnosis of DRESS syndrome or the first five criteria required for diagnosis of atypical DIHS''
|-
|-
| Hospitalization || Maculopapular rash > 3 weeks following administration of drug
| Hospitalization || Maculopapular rash > 3 weeks following administration of drug
Line 31: Line 31:
| || [[Human herpesvirus 6]] reactivation
| || [[Human herpesvirus 6]] reactivation
|}
|}


==References==
==References==

Revision as of 13:41, 21 September 2015

DRESS syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating DRESS syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

DRESS syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of DRESS syndrome

All Images
syndrome X-ray X-rays
syndrome Ultrasound Echo & Ultrasound
syndrome CT CT Images
syndrome MRI MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on DRESS syndrome

CDC on DRESS syndrome

DRESS syndrome in the news

Blogs on DRESS syndrome

Directions to Hospitals Treating DRESS syndrome

Risk calculators and risk factors for DRESS syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Diagnostic Criteria

  • There is no gold standard for the diagnosis of DRESS syndome.
  • Two diagnostic criteria have been proposed:
  • The RegiSCAR criteria [1]
  • The Japanese consensus group criteria[2] are detailed in the table below.
RegiSCAR inclusion criteria for DRESS syndrome.
At least three of the four starred criteria are required for diagnosis
Japanese consensus group diagnostic criteria for DIHS.
Seven criteria needed for the diagnosis of DRESS syndrome or the first five criteria required for diagnosis of atypical DIHS
Hospitalization Maculopapular rash > 3 weeks following administration of drug
Reaction suspected to be drug-related Prolonged clinical symptoms 2 weeks following the discontinuation of the suspected drug
Acute Rash* Fever > 38 °C
Fever > 38 °C* Liver function test abnormalities (ALT > 100 U/L) or other organ involvement
Lymphadenopathy in at least two sites* Leukocyte abnormalities
Involvement of at least one internal organ* Leukocytosis ( > 11 x 109/L)
Blood count abnormalities (lymphopenia or lymphocytosis*, eosinophilia*, thrombocytopenia*) Atypical lymphocytosis (>5%)
Lymphadenopathy
Human herpesvirus 6 reactivation

References

  1. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. (2007). "Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?". Response Br J Dermatol. 156 (3): 609–610. doi:10.1111/j.1365-2133.2006.07704.x. PMID 17300272.
  2. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. (2007). "The diagnosis of DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations". Response Br J Dermatol. 156 (5): 1045–92. doi:10.1111/j.1365-2133.2007.07807.x. PMID 17381452.